IPO registrations (S-1, F-1) · Registrants

STANDARD BIOTOOLS INC.

SEC CIK
1162194 · filings on EDGAR ↗
Name on the registration
FLUIDIGM CORP
Former names
FLUIDIGM CORP (2002–2022)
Registration
Form S-1, first filed 2008-04-14, last 2011-02-09; 2 initial registrations, 17 amendments
Outcome
Final prospectus filed 2011-02-10; declared effective 2011-02-09; withdrawal requested 2008-09-26
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
50 MILK STREET, 10TH FLOOR, Boston, MA 02109
EIN
77-0513190
Ticker
LAB (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
STANDARD BIOTOOLS INC. on the corporate pages

Offering terms

Proposed price range
$13.50–$15.50 per share (S-1/A filed 2011-02-09)
Final price
$13.50 per share, within the range (424B1 filed 2011-02-10, an initial public offering)
Shares sold
5,558,333
Gross proceeds
$75,037,495 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol FLDM
Lead underwriters
Deutsche Bank
Syndicate
Piper Sandler; Cowen; Leerink Partners; December 31 (2,009); respectively) (4,706)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 25

FiledFormWhat it isName as filedEDGAR
2008-04-14S-1S-1 (registration)FLUIDIGM CORP0000950134-08-006517 ↗
2008-05-27S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-010232 ↗
2008-05-30S-1/AS-1/A (amendment)FLUIDIGM CORP0000891618-08-000292 ↗
2008-07-07S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-012379 ↗
2008-07-18S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-012942 ↗
2008-08-13S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-015087 ↗
2008-08-27S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-015833 ↗
2008-09-05S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-016209 ↗
2008-09-15S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-016569 ↗
2008-09-17S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-016723 ↗
2008-09-18S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-016803 ↗
2008-09-22S-1/AS-1/A (amendment)FLUIDIGM CORP0000950134-08-016945 ↗
2008-09-26RWRW (withdrawal request)FLUIDIGM CORP0000950134-08-017178 ↗
2008-10-07RWRW (withdrawal request)FLUIDIGM CORP0000950134-08-017657 ↗
2010-12-03S-1S-1 (registration)FLUIDIGM CORP0001193125-10-273807 ↗
2011-01-07S-1/AS-1/A (amendment)FLUIDIGM CORP0001193125-11-003819 ↗
2011-01-18S-1/AS-1/A (amendment)FLUIDIGM CORP0001193125-11-008513 ↗
2011-01-28S-1/AS-1/A (amendment)FLUIDIGM CORP0001193125-11-016501 ↗
2011-02-02S-1/AS-1/A (amendment)FLUIDIGM CORP0001193125-11-022042 ↗
2011-02-07S-1/AS-1/A (amendment)FLUIDIGM CORP0001193125-11-025233 ↗
2011-02-09S-1/AS-1/A (amendment)FLUIDIGM CORP0001193125-11-028760 ↗
2011-02-09EFFECTEFFECT (declared effective)FLUIDIGM CORP9999999995-11-000385 ↗
2011-02-10S-1MEFS-1MEF (added securities)FLUIDIGM CORP0001193125-11-029728 ↗
2011-02-10424B1424B1 (final prospectus)FLUIDIGM CORP0001193125-11-030835 ↗
2012-05-10EFFECTEFFECT (declared effective)FLUIDIGM CORP9999999995-12-001509 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2011-02-09S-1/Aregistration statement$13.50–$15.50$8.375,172,414$43,293,105Nasdaq FLDM6primary document; range, price line, shares headline, proceeds computed, underwriting table 2, cover names 4document ↗
2011-02-10424B1final prospectus$13.505,558,333$75,037,495Nasdaq FLDM6primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
COLELLA SAMUEL DDirector372011–2020
EuclidSR Biotechnology Partners, L.P.TenPercentOwner22011
EuclidSR Partners, L.P.TenPercentOwner22011
JOG VIKRAMOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER992011–2023
JONES ROBERT COfficerEVP, Research & Development; EVP, RESEARCH & DEVELOPMENT; Exec. VP, Research & Dev.; See Remarks462011–2016
Loh JeremyDirector22011
NUSSBACHER KENNETH JDirector32011
Smith William MaxwellOfficerEVP, Legal Affairs; EVP, Legal Affairs & GC; EVP, LEGAL AFFAIRS & GC; See General Remarks; see remarks; See Remarks; VP, Legal Affairs & GC; VP, LEGAL AFFAIRS & GC692011–2016
VERSANT AFFILIATES FUND I-A LPTenPercentOwner42011
VERSANT AFFILIATES FUND I-B LPTenPercentOwner42011
VERSANT SIDE FUND I LPTenPercentOwner42011
VERSANT VENTURE CAPITAL I LPTenPercentOwner42011
Walder Fredric TOfficerChief Business Officer; CHIEF BUSINESS OFFICER; CHIEF OPERATING OFFICER; See Remarks192011–2015
Whitaker Raymond JDirector22011
Worthington Gajus VincentDirector,Officer; Officer; OtherCHIEF EXECUTIVE OFFICER; President & CEO; PRESIDENT & CEO; President, CEO and Director702011–2016
YOUNG JOHN ADirector92011–2017
Yow Mai ChanOfficerSee Remarks; VP, WW Mfg & MD-Singapore382011–2018
Biomedical Sciences Investment Fund Pte Ltd.TenPercentOwner22011
EDB Investments Pte Ltd.TenPercentOwner22011
SINGAPORE BIO INNOVATIONS PTE LTDTenPercentOwner22011
JONES PATRICK SDirector122011–2019
JONES EVAN/ FADirector; Director,TenPercentOwner222011–2017
Burbach Gerhard FDirector172013–2022
McPhail StevenOfficerChief Commercial Officer; GM, PRODUCTION GENOMICS242015–2019
UNGER MARCOfficerEVP, R&D and Marketing; See Remarks82015–2016
LEE JENNIFER LINGOfficerSee Remarks82016–2018
Khadder NicholasOfficerSee Remarks; SVP, Gen. Counsel & Secretary292016–2022
Linthwaite Stephen ChristopherOfficerPresident & CEO; President & COO332016–2022
Bi-Directional Disequilibrium Fund, L.P.TenPercentOwnerOther842016–2019
LCS Event Partners, LLCTenPercentOwnerOther792016–2018
LCS, LLCTenPercentOwnerOther652016–2019
LCS L/S, LLCTenPercentOwnerOther792016–2018
Levcap Alternative Fund, L.P.Other; TenPercentOwnerOther782016–2018
Levin Capital Strategies GP, LLCTenPercentOwnerOther842016–2019
LEVIN CAPITAL STRATEGIES, L.P.TenPercentOwnerOther942016–2019
Safinia Partners, L.P.TenPercentOwnerOther782016–2018
LEVIN JOHN ATenPercentOwnerOther832016–2019
BARTHELEMY NICOLASDirector222017–2022
Paya Carlos VDirector192017–2023
Kreger Bradley AllenOfficerSVP, Global Operations192018–2022
Clague LauraDirector82018–2023
Crate Darrell WTenPercentOwnerOther112019
Kalichstein AvshalomTenPercentOwnerOther112019
LE Partners Holdings III LLCTenPercentOwnerOther112019
LE Partners Holdings II LLCTenPercentOwnerOther112019
LE Partners Holdings IV LLCTenPercentOwnerOther112019
LE Partners Holdings LLCTenPercentOwnerOther112019
Levin Easterly Partners LLCTenPercentOwnerOther112019
Murphy John WTenPercentOwnerOther112019
McCracken ColinOfficerChief Commercial Officer162019–2022
Colston BillDirector62019–2022
Stankovic Ana K.Director32020–2021
Caligan Partners LPTenPercentOwner; TenPercentOwnerOther112021–2023
JOHNSON DAVID EDWARDTenPercentOwner102021–2023
Casdin Capital, LLCDirector,TenPercentOwner282022–2025
Casdin EliDirector; Director,TenPercentOwner362022–2026
Casdin Partners GP, LLCDirector,TenPercentOwner282022–2025
Casdin Partners Master Fund, L.P.Director; Director,TenPercentOwner282022–2025
Casdin Private Growth Equity Fund II GP, LLCDirector; Director,TenPercentOwner282022–2025
Casdin Private Growth Equity Fund II, L.P.Director; Director,TenPercentOwner282022–2025
Davis Jeremy StevenOfficerSVP Chief Commercial Officer42022–2023
Egholm MichaelDirector,OfficerPresident & CEO232022–2026
Kim Hanjoon AlexOfficerChief Financial Officer; Chief Operating Officer192022–2026
Madaus Martin DDirector62022–2023
Witney FrankDirector72022–2026
ELOI FENEL MDirector62023–2026
Black Jeffrey G.OfficerSVP & Chief Financial Officer72023–2024
Casdin Partners FO1-MSV, LPDirector92023–2024
Carey Thomas D.Director72024–2026person page Fuzzy
CASDIN PRIVATE GROWTH EQUITY FUND GP, LLCDirector252024–2025
Casdin Private Growth Equity Fund, L.P.Director252024–2025
Cox TroyDirector82024–2026
HIBBS KATHY LDirector52024–2026
HALVORSEN OLE ANDREASTenPercentOwner12024person page Fuzzy
Ott David C.TenPercentOwner12024
Shabet Rose SharonTenPercentOwner12024
VIKING GLOBAL INVESTORS LPTenPercentOwner12024
Viking Global Opportunities GP LLCTenPercentOwner12024
Viking Global Opportunities Illiquid Investments Sub-Master LPTenPercentOwner12024
Viking Global Opportunities Parent GP LLCTenPercentOwner12024
Viking Global Opportunities Portfolio GP LLCTenPercentOwner12024
Casdin Amplify Fund, LPDirector; TenPercentOwner102024–2025
Mackay SeanOfficerSVP & Chief Business Officer122024–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2014-02-28FLUIDIGM CORPBiotechnology$76,804,578$76,804,578241

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Investment adviserBEACON ASSET MANAGEMENTMAInvestment advisers (Form ADV)same street address and ZIP code, 50 MILK ST 10TH FL 02109 (FUZZY: a shared address, not proof of a shared organization)
Business registrationStandard BioTools Inc.MAState business registriesname and state
Business registrationSTANDARD BIOTOOLS INC.MAState business registriesname and state
Business registrationSTANDARD BIOTOOLS INC.MAState business registriesname and state
Business registrationSTANDARD BIOTOOLS INC.MAState business registriesname and state
Form D issuerFLUIDIGM CORPCAForm D private offeringsCIK (EXACT)
SEC filerSTANDARD BIOTOOLS INC.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorSTANDARD BIOTOOLS INC.EIN (EXACT)
Person pageOle Andreas HalvorsenPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)
Person pageThomas D CareyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Pharmaceutical Preparations · Health